Archive for 2020

TissueTech Appoints Denise Spencer Vice President of Human Resources

Change champion will focus on aligning associates with organization’s mission, vision, and values in accordance with strategic business objectives Miami, FL – December 7, 2020 – TissueTech, Inc., a pioneer in the clinical application of cryopreserved amniotic membrane and umbilical cord birth tissue allografts, announced today that Denise Spencer, MBA and Senior Professional in Human […]

Newly Published Study Results Show that Patients with Infectious Corneal Ulcers had Significantly Faster Epithelialization and better Visual Acuity than Standard of Care (SOC) After Receiving Placement of Cryopreserved Amniotic Membrane

Bio-Tissue

Post-treatment application of Cryopreserved Amniotic Membrane (PROKERA® Slim) may be useful in treating sight-threatening infectious corneal ulcers by promoting faster corneal epithelialization and overall better recovery of Visual Acuity Miami, FL – November 19, 2020 – Bio-Tissue, Inc. (Bio-Tissue), a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue-based products for […]

TissueTech Announces Engagement of Pro-ficiency Virtual Study Trainer™ for Clinical Trials

Miami, FL – November 19, 2020 – TissueTech, Inc., an emerging biotechnology company and pioneer in the clinical application of cryopreserved amniotic membrane and umbilical cord birth tissue allografts, announced today the engagement of Pro-ficiency Virtual Study Trainer™ to facilitate remote study protocol training for TissueTech’s clinical trial investigators and their clinical research teams. TissueTech […]

Amniox Launches Virtual Education and Diabetic Foot Ulcer Outreach Campaign to Support National Diabetes Month

Amniox Medical

Month-long campaign features a host of educational activities focusing on management of complex, chronic wounds resulting from diabetes Miami, FL – November 10, 2020 – Amniox Medical, Inc. (Amniox), a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue-based products, announced today that it had joined forces with key stakeholder groups […]

Recently Published Study Suggests CLARIX FLO Amniotic Membrane/Umbilical Cord Particulate Provides Benefits in Moderate to Severe Knee Osteoarthritis

Amniox Medical

74% of patients treated with CLARIX® FLO demonstrated clinically significant improvement at 12 months, signifying its potential in delaying Total Knee Arthroplasty (TKA) Miami, FL – November 9, 2020 – Amniox Medical, Inc. (Amniox), a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue-based products, announced today the results from a […]

TissueTech Adds eKare’s Remote Wound Monitoring Solutions to its Host of Virtual Oversight Tools Used in Late-Phase Research of Biologic Candidate TTAX01 to Treat Complex Wagner Grade 3 and 4 Diabetic Foot Ulcers (DFUs)

Amniox Medical

Virtual technologies minimize risks associated with in-person patient visits, gives investigators the ability to monitor DFU wound healing in real-time via a telehealth platform Miami, FL – October 29, 2020 –TissueTech, Inc., a pioneer in the clinical application of cryopreserved amniotic membrane and umbilical cord birth tissue allografts, announced today that they had selected the […]

Encouraging Outcomes Data with Surgical Repair of Chronic, Large, Refractory Macular Holes Using AmnioGraft® Cryopreserved Amniotic Membrane

Bio-Tissue

Miami, FL – September 14, 2020 — Bio-Tissue, Inc., a TissueTech, Inc. company and leader in the clinical application of Cryopreserved Amniotic Membrane and Umbilical Cord tissue allografts for ocular surface disease, announced today the case series outcome of surgical repair of large macular holes using AmnioGraft Cryopreserved Amniotic Membrane. Results have shown that the placement of AmnioGraft may be a feasible alternative to conventional surgical methods to improve anatomic and visual outcomes.1

TissueTech to Collaborate with Johns Hopkins University-based Investigators to Study the Use of Cryopreserved Amniotic Membrane and Umbilical Cord for the Non-Opioid Treatment of Post-Surgical Pain

Amniox Medical

Miami, FL – August 17, 2020 – Amniox Medical, Inc. (Amniox), a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue-based products, announced today that Yun Guan, MD, PhD, professor of anesthesiology and critical care medicine, and professor of neurological surgery at the Johns Hopkins University School of Medicine, has been awarded a 5-year R01 grant from the National Institutes of Health (NIH) for a study titled “Birth Tissue Products for Non-opioid Treatment of Post-surgical Pain.” Dr. Guan and his team will study the efficacy and molecular mechanism, thereby human birth tissue promotes wound healing and suppresses pain after surgical procedures. TissueTech will serve as a sub-contractor on the project.

PROKERA® Slim Corneal Bandage Now Approved in Taiwan for Treatment of Ocular Wounds

Bio-Tissue

Provides Taiwan eye care professionals with a well-established product to support healing in corneal-involved dry eye, keratitis, recurrent corneal erosions, and other ocular surface diseases Miami, FL – August 5, 2020 — Bio-Tissue, Inc., a TissueTech, Inc. company and leader in the clinical application of human birth tissue products for ocular surface disease and disorders, […]

SAWC Spring Meeting Features Symposium on Promising Advancements in the Treatment of Complex Wounds

Amniox Medical

Virtual symposium showcases results from study follow-up in which 86.2% of patients achieved complete closure of Wagner Grade 3-4 Diabetic Foot Ulcers (DFUs) with TTAX01 Cryopreserved Umbilical Cord allograft. Miami, FL – July 27, 2020 – Amniox Medical, Inc. (Amniox), a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue-based products, […]

Archives

  • 2021
  • 2020
  • 2019
  • 2018